Carvedilol
Product Images NDC 13107-142

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 13107-142). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurolife Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Survival Analysis For Capricorn (intent-to-treat) (Carvedilol Fig1)

Figure 1. Survival Analysis For Capricorn (intent-to-treat) (Carvedilol Fig1)
This appears to be a graph displaying mortality rates with a range of 30% to 10% and two data sets: "Placebo" and "Carvedilol." The annotation "P=003" likely indicates a statistical significance level.*
FDA Label Image

Figure 2. Effects On Mortality For Subgroups In Capricorn (Carvedilol Fig2)

FDA Label Image

Package Label-principal Display Panel (3.125 mg (1000 Tablet Bottle))

Package Label-principal Display Panel (3.125 mg (1000 Tablet Bottle))
The text is a description of Carvedilol Tablets, US 3.125 mg. The tablets are film-coated and come in a tight, light-resistant container. They should be stored at a temperature between 20 and 25°C to protect them from moisture. The tablets are manufactured by Aurolife Pharma LLC and distributed by Aurobindo Pharma USA, Inc. The text includes dosage information as well as safety recommendations for dispensing the product. The batch number and expiry date are also provided.*
FDA Label Image

Package Label-principal Display Panel (6.25 mg (1000 Tablet Bottle))

Package Label-principal Display Panel (6.25 mg (1000 Tablet Bottle))
This is a description of a medication called Carvedilol. It is a film-coated tablet containing 6.25mg of Carvedilol USP. It is important to use safety closures when dispensing this product unless otherwise directed by a physician or requested by the purchaser. It must be dispensed in a tight, light-resistant container and stored at 20 to 25°C to protect from moisture. There are no dosage instructions provided, so the patient should refer to the accompanying prescribing information. Pharmacist should dispense the accompanying patient information leaflet to each patient. The medication was manufactured by Aurolife Pharma LLC for Aurobindo Pharma USA, Inc. The batch number and expiry date are also listed.*
FDA Label Image

Package Label-principal Display Panel (12.5 mg (1000 Tablet Bottle))

Package Label-principal Display Panel (12.5 mg (1000 Tablet Bottle))
Each tablet of this medicine contains 12.5 mg of Carvedilol USP. It should be stored in a tightly closed container away from moisture at controlled room temperature. Safety closures should be used when dispensing the product. The accompanying Patient Information Leaflet should be given to each patient by the pharmacist. The details of the batch and expiry date are not available. This medicine is only available with a prescription.*
FDA Label Image

Package Label-principal Display Panel (25 mg (1000 Tablet Bottle))

Package Label-principal Display Panel (25 mg (1000 Tablet Bottle))
Each tablet of Carvedilol USP contains 25mg of the active ingredient. It is manufactured by Aurolife Pharma LLC and distributed by Aurobindo Pharma USA Inc. The usual dosage information is available in the accompanying prescribing information. The tablets should be stored in a cool, dry place, away from moisture and light. Dispense in a tight, light-resistant container with a patient information leaflet included for each patient. Use safety closures when dispensing the product.*
FDA Label Image

Carvedilol Structure (Carvedilol Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.